{
  "type": "article",
  "title": "Paras Healthcare Shares Debut at 3.90% Premium on Exchanges, Climb to Rs 740 in Morning Trade",
  "summary": "Paras Healthcare listed on the NSE and BSE at Rs 720 apiece against its IPO issue price of Rs 693, beating subdued grey market expectations. Strong buying in early trade lifted the stock above Rs 740, delivering gains of up to Rs 966 per allotted lot.",
  "content": "Shares of hospital chain operator Paras Healthcare began trading on the Indian stock exchanges on Wednesday, October 28, opening at a premium of 3.90 percent over their issue price before extending their gains during the early trading session. The equity shares debuted at Rs 720 on both the BSE and the National Stock Exchange of India, marking a clean start against the initial public offering price of Rs 693. Strong interest from market participants immediately after the opening bell helped the newly listed stock advance further above its listing price.\n\nEarly Morning Rally Across Exchanges\nBy 10:15 AM, the upward momentum lifted Paras Healthcare shares to Rs 739 on the NSE, representing an advance of 2.64 percent from the opening tick and an overall climb of 6.64 percent above the issue price. Trading activity was equally upbeat on the BSE, where the stock changed hands at Rs 740.25. At this level, the share price was up 2.81 percent from its opening quote and 6.82 percent higher than the upper band of the IPO price. Both exchanges recorded steady transaction volumes as buyers absorbed shares from early allotment holders looking to book listing gains.\n\nAllotment Mathematics and Investor Earnings\nFor retail investors who received shares through the allotment process, the minimum bidding application was set at a single lot comprising 21 shares. At the final issue price of Rs 693, bidding for one lot required a capital commitment of Rs 14,553. When trading commenced at Rs 720, the valuation of that single lot rose to Rs 15,120, translating into an immediate gross listing profit of Rs 567 per lot. As buying picked up and the NSE quote advanced to Rs 739 during the morning run, the market value of the 21-share lot reached Rs 15,519, expanding the unrealized profit to Rs 966 per allotted lot.\n\nPerformance Outpaces Softening Grey Market Signals\nThe positive listing surprised participants who had tracked unofficial grey market trading ahead of the debut. The grey market premium had steadily tapered down to roughly Rs 13 immediately prior to listing, implying an expected opening price around Rs 706, substantially lower than the actual Rs 720 opening level. In contrast, grey market sentiment had been considerably firmer when the issue first opened for bidding on October 21, with the unofficial premium quoted at Rs 40 before gradually eroding over the course of the three-day subscription window. The actual exchange debut demonstrated that institutional and retail demand on the open market proved stronger than the unorganised pre-market quotes indicated.\n\nIssue Details and Fundraising Structure\nThe public offering of Paras Healthcare raised a total of Rs 1,450 crore and remained open for subscription between October 21 and October 23, with the price band established between Rs 660 and Rs 693 per equity share. The fundraising structure comprised a fresh issue of shares aggregating Rs 500 crore alongside an offer for sale component amounting to Rs 950 crore. Under the OFS portion, promoter Dharminder Kumar Nagar and financial investor Commelina offloaded part of their holdings. Prior to finalising this structure, the healthcare services provider had originally filed draft paperwork proposing a larger public issue of Rs 1,800 crore before scaling it down to the final size.\n\nAnchor Allocation and Deployment of Fresh Proceeds\nAhead of opening the books to public bids, Paras Healthcare mobilized Rs 652.30 crore from 39 anchor investors at the upper price band of Rs 693 per share. The management has clearly earmarked the intended usage of the Rs 500 crore fresh capital. Up to Rs 375 crore will be utilized toward the repayment or prepayment of outstanding borrowings taken by the parent firm and its operating subsidiary. The residual portion of the net fresh proceeds will be channelled into general corporate purposes, supporting working capital requirements and day-to-day operational liquidity.\n\nBrokerage Perspective and Long-Term Projections\nInstitutional analysts have begun formal evaluation of the newly listed healthcare firm. Choice Institutional Equities initiated coverage on the company with a buy recommendation, noting, \"We project Revenue/EBITDA/PAT to expand at a CAGR of 21.9%/29.4%/99.1% over FY26-29E.\" The brokerage attributed this growth trajectory to an expanding portfolio of high-value specialized medical care, the strategic rollout of established regional hospital facilities into underserved secondary markets, and expanding operating leverage stemming from improved bed occupancy and clinical capacity utilization. Backed by a discounted cash flow methodology implying an enterprise value to EBITDA multiple of 14 times on projected fiscal 2029 earnings, the brokerage pegged a target price of Rs 900 on the counter, indicating an upside potential of approximately 30 percent from the issue price.\n\nWhat this means for you\nThe market debut of Paras Healthcare delivers immediate cash gains for successful retail bidders while opening a fresh listed equity route for investors tracking the Indian healthcare sector.\n\n• Allotted Retail Investors: Successful applicants earned an immediate profit of up to Rs 966 per 21-share lot during early morning trading. Investors have the option to lock in these listing gains or hold the position for potential long-term appreciation.\n• Prospective Secondary Market Buyers: Shares are trading in the Rs 739 to Rs 740 corridor, remaining above the initial offer price of Rs 693. With institutional research projecting a price target of Rs 900, fresh buyers may assess entry points based on long-term capacity utilization.\n• Corporate Balance Sheet Impact: Utilizing up to Rs 375 crore from fresh proceeds to retire debt will reduce ongoing finance costs for the company and its subsidiary. Lower interest outgo is expected to enhance operational margins and future cash flows.\n• Healthcare Sector Allocations: The listing broadens the listed hospital peer group focused on underserved regional markets. Portfolio managers and retail participants now have another vehicle to capture rising domestic demand for specialized medical treatments.\n\nWhy this happened\nThe solid debut and early price run of Paras Healthcare were driven by robust institutional participation, explicit debt repayment targets, and a constructive earnings trajectory outlined by analysts.\n\n• Anchored Institutional Confidence: Mobilizing Rs 652.30 crore from 39 anchor investors ahead of public bidding set a firm valuation benchmark. This pre-issue backing reassured the secondary market despite fluctuating sentiment in the informal grey market.\n• Balance Sheet Deleveraging Strategy: Earmarking up to Rs 375 crore from the Rs 500 crore fresh issue exclusively for debt repayment removes interest drag from future earnings. Investors favored the prompt reduction in aggregate borrowing across the parent entity and operating subsidiary.\n• Absorption of Grey Market Weakness: While informal GMP softened to Rs 13 right before the debut, genuine institutional and retail exchange demand easily overwhelmed pre-market pessimism, lifting quotes from Rs 720 to above Rs 740.\n• Supportive Brokerage Projections: Initiation of research coverage with a buy rating and an estimated 99.1 percent profit CAGR over fiscal 2026 through 2029 provided fundamental validation for morning buyers seeking post-listing momentum.\n\nQuestions & Answers\n\n1. At what price did Paras Healthcare shares list on the exchanges?\nThe shares debuted at Rs 720 on both the NSE and the BSE, representing a 3.90% premium over the issue price of Rs 693.\n\n2. How high did the stock climb during early trading?\nIn morning trade, the stock reached Rs 739 on the NSE (up 6.64% over issue price) and Rs 740.25 on the BSE (up 6.82%).\n\n3. How much did an allottee make on a single lot?\nFor a 21-share lot, investors earned Rs 567 at the opening price of Rs 720 and Rs 966 when the price hit Rs 739.\n\n4. What was the total size of the Paras Healthcare IPO?\nThe overall issue was valued at Rs 1,450 crore, comprising a Rs 500 crore fresh issue and a Rs 950 crore offer for sale.\n\n5. How will the proceeds from the fresh issue be utilized?\nThe company will deploy up to Rs 375 crore to repay borrowings across itself and its subsidiary, with the remainder for general corporate purposes.\n\n6. What rating and price target did Choice Institutional Equities assign?\nChoice Institutional Equities initiated coverage with a 'BUY' rating and set a target price of Rs 900.",
  "url": "https://trendkia.com/en/business/paras-healthcare-ke-sheyaron-ne-sheyara-bajara-men-di-dastaka-shuruati-karobara-men-ishyu-praisa-se-6-82-taka-uchhale-52486",
  "category": "Business",
  "publishedAt": "2026-10-28",
  "tags": [
    "Paras Healthcare",
    "IPO Listing",
    "Stock Market",
    "NSE",
    "BSE",
    "Healthcare Stocks",
    "Listing Gains"
  ],
  "language": "en",
  "site": "TrendKia"
}